Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Allergy Tx hit hard as birch pollen product stumbles

Shares in the company went into a steep decline this morning

- PMLiVE

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech

- PMLiVE

Bringing life to precision medicine

Harnessing the power of patient-derived organoids

- PMLiVE

Keytruda adds another NSCLC approval in Europe

Squamous NSCLC completes first-line dominance

Measures for measures

Why pharma’s marketing metrics must close the loop

Lucid Group Communications Limited

- PMLiVE

Gottlieb admonishes industry for clinical trial failings

Calls for faster uptake of novel trial design and methods

- PMLiVE

CHMP recommends new Keytruda dosing schedule

Will apply to eight indications across five tumour types

- PMLiVE

Liver specialist Genfit files $120m IPO on Nasdaq

Funds will go towards NASH candidate, a companion diagnostic and a liver disease drug

- PMLiVE

Francis exits Sandoz, reigniting spinoff rumours

Novartis says no such plans at present

- PMLiVE

Pharma Careers Q&A: Caroline Benson

Gemma Jones interviews Cuttsy+Cuttsy's Co-Founder and Director

- PMLiVE

ROAD wins new account

Theramex appoints the PR and digital comms group to work on Actonel GR

AstraZeneca AZ

AZ to address Imfinzi setback, but sees potential with Tagrisso

Pharma giant to deliver oncology pipeline update at AACR

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links